ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 173 filers reported holding ACCELERON PHARMA INC in Q3 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,039,000 | +37.4% | 6,036 | +0.2% | 0.01% | +50.0% |
| Q2 2021 | $756,000 | -7.1% | 6,021 | +0.3% | 0.00% | -20.0% |
| Q1 2021 | $814,000 | -7.2% | 6,001 | -12.4% | 0.01% | 0.0% |
| Q4 2020 | $877,000 | +43.1% | 6,853 | +25.9% | 0.01% | +25.0% |
| Q3 2020 | $613,000 | +18.1% | 5,443 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $519,000 | +56.3% | 5,443 | +47.5% | 0.00% | +33.3% |
| Q1 2020 | $332,000 | +87.6% | 3,690 | +10.7% | 0.00% | +200.0% |
| Q4 2019 | $177,000 | +51.3% | 3,333 | +12.7% | 0.00% | 0.0% |
| Q3 2019 | $117,000 | -4.1% | 2,958 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $122,000 | -11.6% | 2,958 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $138,000 | +22.1% | 2,958 | +13.7% | 0.00% | 0.0% |
| Q4 2018 | $113,000 | -11.0% | 2,602 | +17.4% | 0.00% | 0.0% |
| Q3 2018 | $127,000 | +60.8% | 2,216 | +36.1% | 0.00% | 0.0% |
| Q2 2018 | $79,000 | +23.4% | 1,628 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $64,000 | -7.2% | 1,628 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $69,000 | +81.6% | 1,628 | +59.0% | 0.00% | – |
| Q3 2017 | $38,000 | +22.6% | 1,024 | 0.0% | 0.00% | – |
| Q2 2017 | $31,000 | +14.8% | 1,024 | 0.0% | 0.00% | – |
| Q1 2017 | $27,000 | +3.8% | 1,024 | 0.0% | 0.00% | – |
| Q4 2016 | $26,000 | -29.7% | 1,024 | 0.0% | 0.00% | – |
| Q3 2016 | $37,000 | +32.1% | 1,024 | +23.8% | 0.00% | – |
| Q2 2016 | $28,000 | +27.3% | 827 | 0.0% | 0.00% | – |
| Q1 2016 | $22,000 | -45.0% | 827 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $40,000 | +471.4% | 827 | +188.2% | 0.00% | – |
| Q3 2015 | $7,000 | – | 287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |